Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients–A Single-Center Experience
Vaccination against SARS-CoV-2 infection is currently approved and shows favorable outcomes, but little known about antibody responses in solid organ transplant recipients, since these patients are known to have an impaired immune response upon vaccination and have not been included in admission stu...
Main Authors: | Jassin Rashidi-Alavijeh, Alexandra Frey, Moritz Passenberg, Johannes Korth, Jaqueline Zmudzinski, Olympia E. Anastasiou, Fuat H. Saner, Michael Jahn, Christian M. Lange, Katharina Willuweit |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/7/738 |
Similar Items
-
Predictive Factors of Intensive Care Length of Stay in Liver Transplant Recipients
by: Rowe, Lynn A.
Published: (2014) -
Evaluation of liver transplant recipients underwent incidental appendectomies
by: Cemalettin Koc, et al.
Published: (2020-08-01) -
Prevalence of Metabolic Syndrome in Liver Transplant Recipients in Iran
by: SJ Masoumi, et al.
Published: (2016-04-01) -
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)
by: Johannes Korth, et al.
Published: (2021-04-01) -
Quality of life among liver transplantation recipients before and after surgery: A single-center longitudinal study
by: Alireza Shamsaeefar, et al.
Published: (2020-01-01)